# Validation Summary: Diabetes Risk Prediction Model

## 1. Validation Objective

The objective of validation was to evaluate whether machine learning models could predict diabetes risk from structured clinical variables.

The validation focused on both technical performance and healthcare-relevant classification metrics.

---

## 2. Models Evaluated

Two models were evaluated:

1. Logistic Regression
2. Random Forest Classifier

Logistic Regression was used as the interpretable baseline model.

Random Forest was used as the non-linear ensemble model.

---

## 3. Data Splitting Strategy

The dataset was split into training and test sets using stratified sampling.

Stratification was used to preserve the proportion of diabetes and non-diabetes outcomes in both training and test sets.

Preprocessing was fitted only on the training data to reduce data leakage risk.

---

## 4. Preprocessing

Preprocessing steps included:

- Handling clinically invalid zero values where applicable
- Median imputation
- Feature scaling for Logistic Regression
- Pipeline-based preprocessing
- Separation of features and target before model training

The target variable was not used during preprocessing of input features.

---

## 5. Evaluation Metrics

The following metrics were used:

- ROC-AUC
- Accuracy
- Sensitivity
- Specificity
- Precision
- F1-score
- Matthews Correlation Coefficient
- Cohen’s Kappa
- Confusion Matrix

Healthcare screening models should not be evaluated using accuracy alone.

Sensitivity and specificity are important because they describe false-negative and false-positive behavior.

---

## 6. Threshold Optimization

Threshold optimization was performed to evaluate how different probability cutoffs affect model sensitivity and specificity.

In healthcare screening, threshold selection should be guided by clinical risk, not only by mathematical performance.

The selected threshold should be externally validated before real-world use.

---

## 7. Explainability Validation

Feature importance and SHAP explainability were used to understand the model’s prediction behavior.

Explainability helped identify influential variables such as glucose, BMI, age, and insulin.

These findings were reviewed for clinical plausibility.

---

## 8. Current Validation Limitations

Current validation limitations include:

- No external validation dataset
- No prospective validation
- No subgroup fairness analysis
- No model calibration analysis
- Limited sample size
- Dataset may not represent real diagnostic laboratory populations
- No real-world laboratory workflow validation

---

## 9. Future Validation Plan

Future improvements should include:

- Repeated stratified cross-validation
- Confidence intervals for performance metrics
- Calibration curve
- Brier score
- Subgroup analysis
- External validation on local population data
- Validation using real diagnostic laboratory data
- Clinical review of risk categories
- Human-in-the-loop evaluation

---

## 10. Validation Conclusion

The model shows promising performance as an educational healthcare ML prototype.

However, the model is not clinically validated and should not be used for diagnosis or treatment decisions.

Further validation is required before considering real-world clinical or laboratory use.